Phase I trial of single and multiple doses of intravenous POL 7080 in healthy male volunteers in Europe.
Phase of Trial: Phase I
Latest Information Update: 05 Feb 2018
Price : $35 *
At a glance
- Drugs Murepavadin (Primary)
- Indications Pseudomonal infections
- Focus Adverse reactions
- 05 Feb 2018 Results assessing (n=52) tolerability and pharmacokinetics of POL 7080 after single and multiple IV infusions in healthy male volunteers.published in the Antimicrobial Agents and Chemotherapy.
- 05 Mar 2013 New trial record